TomoTherapy Incorporated (TOMO) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts TOMO Hot Sheet
Join SI Premium – FREE
TomoTherapy Incorporated (NASDAQ: TOMO) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $46.95 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Nike (NKE) Tops Q1 EPS by 4c
- Cal-Maine Foods stock edges down on first quarter loss and revenue miss
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
